Bristol trial for blood tests to diagnose dementia underway
- A groundbreaking trial to explore the potential of blood tests to diagnose dementia has begun at North Bristol NHS Trust, in collaboration with the University of Bristol.
- The research study marks a significant step toward improving the UK’s dementia diagnosis rate.
- This initiative, led by the READ-OUT (REAl World Dementia OUTcomes) research team at Dementias Platform UK (DPUK), seeks to address gaps in diagnosis and enhance early detection of dementia, ultimately improving outcomes for people living with the condition.
Professor Henrietta Hughes: Putting Patient Safety at the Heart of Regulatory Innovation
- Professor Henrietta Hughes reflects on how MHRA strategy must prioritise patient safety via listening to lived experiences, fostering collaboration & innovation.
- This study hypothesizes that subclinical myocardial injury during midlife, indexed by increases in cardiac troponin I, is associated with accelerated cognitive decline, smaller structural brain volume, and higher risk of dementia.
Patients to benefit from cutting-edge NHS care from their homes
- Dozens of areas across England to roll out new technology that will make care more personalised and free up appointments – up to 500,000 every year when fully operational.
- Thousands of patients to benefit from faster, more convenient care at home, reducing pressure on the NHS ahead of winter.
- Rollout comes as NHS launches world-first trial to support motor neurone disease (MND) remotely.
- CANCER publishes research which indicates that routine liquid biopsy testing (multi-cancer early detection testing) could substantially reduce late-stage cancer diagnoses, allowing patients to receive treatment at earlier stages.
- The study estimates that over 10 years, multi-cancer early detection testing would lead to a 10% increase in stage I diagnoses, a 20% increase in stage II, a 30% increase in stage III, and a 45% decrease in stage IV diagnoses.
